GNXAX
Price
$16.80
Change
-$0.49 (-2.83%)
Updated
Jul 2 closing price
Net Assets
25.85M
RSLBX
Price
$70.40
Change
-$0.84 (-1.18%)
Updated
Jul 2 closing price
Net Assets
91.47B
Interact to see
Advertisement

GNXAX vs RSLBX

GNXAX vs RSLBX Comparison Chart in %
View a ticker or compare two or three
VS
GNXAX vs. RSLBX commentary
Jul 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNXAX is a Hold and RSLBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLBX has more cash in the bank: 91.5B vs. GNXAX (25.8M). RSLBX pays higher dividends than GNXAX: RSLBX (0.14) vs GNXAX (0.00). GNXAX was incepted earlier than RSLBX: GNXAX (9 years) vs RSLBX (24 years). GNXAX (2.84) is less costly to investors than RSLBX (1.74). GNXAX is a more actively managed with annual turnover of: 59.00 vs. RSLBX (41.00). RSLBX has a lower initial minimum investment than GNXAX: RSLBX (250) vs GNXAX (2500). RSLBX annual gain was more profitable for investors over the last year : 14.99 vs. GNXAX (9.02). GNXAX return over 5 years is better than : -5.46 vs. RSLBX (-8.73).
GNXAXRSLBXGNXAX / RSLBX
Total Expense Ratio1.761.74101%
Annual Report Gross Expense Ratio2.841.74163%
Fund Existence9 years24 years-
Gain YTD-4.54514.639-31%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets25.8M91.5B0%
Annual Yield % from dividends0.000.14-
Returns for 1 year9.0214.9960%
Returns for 3 years37.3733.15113%
Returns for 5 years-5.46-8.7363%
Returns for 10 yearsN/A75.65-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DLRHX26.950.63
+2.39%
Nomura Healthcare Fund Class R
FETKX33.190.35
+1.07%
Fidelity Equity Dividend Income K
FERAX14.540.09
+0.62%
First Eagle Global Real Assets A
WPGSX14.80-0.19
-1.27%
WPG Partners Select Small Cap Value Ins
LGILX26.76-0.39
-1.44%
Schwab Select Large Cap Growth